Accuracy of intermittently scanned continuous glucose monitoring during caesarean delivery in pregnant women with insulin-treated diabetes [0.03%]
胰岛素治疗的妊娠糖尿病患者在剖宫产过程中间断扫描连续血糖监测的准确性
Fabrizia Citro,Cristina Bianchi,Michele Aragona et al.
Fabrizia Citro et al.
Aim: Continuous Glucose Monitoring (CGM) systems are not currently recommended to guide intrapartum glucose and insulin infusion, due to insufficient data. In this study, intrapartum accuracy of intermittently scanned CGM...
Not enough known about fenofibrate's kidney effects in people with Type 2 diabetes [0.03%]
对于二型糖尿病患者尚不清楚非诺贝特对肾脏的影响
Alicia J Jenkins,Rachel L O&#x;Connell,Andrzej S Januszewski et al.
Alicia J Jenkins et al.
Globally ≈10% of adults have diabetes, with 80% in disadvantaged regions, hence low-cost renoprotective agents are desirable. Fenofibrate demonstrated microvascular benefits in several cardiovascular end-point diabetes trials, but knowledg...
The hidden epidemic: Uncovering incidental fatty liver disease and its metabolic comorbidities by datamining in a hospital data lake - A real-world cohort study [0.03%]
隐藏的流行病：通过医院数据湖中的数据挖掘揭示意外的脂肪肝疾病及其代谢合并症-一项真实世界队列研究
Iiro P Karhiaho,Samu H Kurki,Helka I Parviainen et al.
Iiro P Karhiaho et al.
Aims: To identify individuals with incidental fatty liver disease (FLD), and to evaluate its prevalence, metabolic co-morbidities and impact on follow-up. ...
Hospitalisation for herpes zoster in people with and without diabetes: A 10-year-observational study [0.03%]
糖尿病患者和非糖尿病患者的带状疱疹住院情况：一项为期十年的观察性研究
Carlo B Giorda,Roberta Picariello,Barbara Tartaglino et al.
Carlo B Giorda et al.
Aims: This study explores the association between Herpes Zoster (HZ) hospitalizations and diabetes in Piedmont, Italy from 2010 to 2019. Focusing on the burden of HZ hospitalizations in diabetic and non-diabetic groups, i...
Observational Study
Diabetes research and clinical practice. 2024 Apr:210:111603. DOI:10.1016/j.diabres.2024.111603 2024
International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes [0.03%]
国际糖尿病联盟关于采用负荷后1小时血浆葡萄糖诊断中间高血糖和2型糖尿病的立场声明
Michael Bergman,Melania Manco,Ilhan Satman et al.
Michael Bergman et al.
Many individuals with intermediate hyperglycaemia (IH), including impaired fasting glycaemia (IFG) and impaired glucose tolerance (IGT), as presently defined, will progress to type 2 diabetes (T2D). There is confirmatory evidence that T2D c...
The association between patterns of weight change, diabetes status and glycaemia among adults with overweight and obesity [0.03%]
超重和肥胖成人中体重变化模式、糖尿病状况和血糖水平之间的关联
Ruoyu Yin,Amy L Ahern,Louise Lafortune et al.
Ruoyu Yin et al.
Aims: To investigate the associations between weight change patterns and 5-year incident non-diabetic hyperglycaemia (NDH), and glycated haemoglobin (HbA1c) levels among individuals who had overweight or obesity. ...
Correlational analysis of PLIN1 with inflammation in diabetic foot ulcer wounds [0.03%]
PLIN1与糖尿病足溃疡伤口炎症的相关性分析
Mengting Wang,Xiaoliang Cao,Yanxing Shang et al.
Mengting Wang et al.
Background: The persistent presence of inflammation is a recognized pathogenic mechanisms of diabetic foot ulcers (DFUs). We aimed to investigate the expression of PLIN1 in tissues from DFU patients and assess its potenti...
Consistent glycaemic efficacy and safety of concomitant use of iGlarLixi and sodium-glucose co-transporter-2 inhibitor therapy for type 2 diabetes: A patient-level pooled analysis of three randomised clinical trials [0.03%]
iGlarLixi与SGLT-2抑制剂联用治疗2型糖尿病的疗效和安全性：三项随机临床试验的患者水平合并分析
Francesco Giorgino,Cristian Guja,Hasan Aydın et al.
Francesco Giorgino et al.
Aims: Sodium glucose co-transporter 2 inhibitors (SGLT2is) and/or glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with proven cardio- and reno-protective benefits are recommended in people with type 2 diabetes (T2D)...
Randomized Controlled Trial
Diabetes research and clinical practice. 2024 Mar:209:111604. DOI:10.1016/j.diabres.2024.111604 2024
Carbohydrate counting knowledge and ambulatory glucose profile in persons living with type 1 diabetes [0.03%]
计数碳水化合物知识和1型糖尿病患者血糖分布情况研究
Sopio Tatulashvili,Bleuenn Dreves,Laurent Meyer et al.
Sopio Tatulashvili et al.
Context: The amount of consumed carbohydrates is the strongest factor influencing glucose levels during the four hours following a meal. Our aim was to evaluate the association between carbohydrate counting knowledge and ...
Telemedicine maintains good glucose control in children with type 1 diabetes but is not time saving for healthcare professionals: KITES randomized study [0.03%]
远程医疗对1型糖尿病儿童维持良好的血糖控制是有效的，但并不能为医务人员节省时间：KITES随机研究
Lukas Plachy,Vit Neuman,Katerina Velichova et al.
Lukas Plachy et al.
Aims: To evaluate glucose control non-inferiority and time benefits of telemedicine follow-up in children with type 1 diabetes (CwD). Methods: ...
Randomized Controlled Trial
Diabetes research and clinical practice. 2024 Mar:209:111602. DOI:10.1016/j.diabres.2024.111602 2024